Matthew Hanley, PhD, is currently the Executive Director of Clinical Science at Eli Lilly and Company, where they have held various positions including Associate Director and Director from 2020 to 2022. Prior to this role, Matthew served as Vice President and Director of R&D at Thetis Pharmaceuticals from 2016 to 2019. They completed their education at The University of Connecticut Health Center from 2012 to 2017.
This person is not in the org chart
This person is not in any teams
This person is not in any offices